295 related articles for article (PubMed ID: 33008530)
41. Sex and gender differences in Alzheimer's disease: current challenges and implications for clinical practice: Position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology.
Ferretti MT; Martinkova J; Biskup E; Benke T; Gialdini G; Nedelska Z; Rauen K; Mantua V; Religa D; Hort J; Santuccione Chadha A; Schmidt R
Eur J Neurol; 2020 Jun; 27(6):928-943. PubMed ID: 32056347
[TBL] [Abstract][Full Text] [Related]
42. Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study.
Mosconi L; Rahman A; Diaz I; Wu X; Scheyer O; Hristov HW; Vallabhajosula S; Isaacson RS; de Leon MJ; Brinton RD
PLoS One; 2018; 13(12):e0207885. PubMed ID: 30540774
[TBL] [Abstract][Full Text] [Related]
43. Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.
Johnson CE; Duncan MJ; Murphy MP
J Alzheimers Dis; 2024; 97(1):31-74. PubMed ID: 38007653
[TBL] [Abstract][Full Text] [Related]
44. Androgens, apoE, and Alzheimer's disease.
Raber J
Sci Aging Knowledge Environ; 2004 Mar; 2004(11):re2. PubMed ID: 15028864
[TBL] [Abstract][Full Text] [Related]
45. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
46. Age, APOE and sex: Triad of risk of Alzheimer's disease.
Riedel BC; Thompson PM; Brinton RD
J Steroid Biochem Mol Biol; 2016 Jun; 160():134-47. PubMed ID: 26969397
[TBL] [Abstract][Full Text] [Related]
47. Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative.
Snyder HM; Asthana S; Bain L; Brinton R; Craft S; Dubal DB; Espeland MA; Gatz M; Mielke MM; Raber J; Rapp PR; Yaffe K; Carrillo MC
Alzheimers Dement; 2016 Nov; 12(11):1186-1196. PubMed ID: 27692800
[TBL] [Abstract][Full Text] [Related]
48. Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer's disease.
Sato K; Takayama KI; Inoue S
Front Endocrinol (Lausanne); 2023; 14():1220150. PubMed ID: 37469978
[TBL] [Abstract][Full Text] [Related]
49. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
Duarte AI; Santos MS; Oliveira CR; Moreira PI
Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
[TBL] [Abstract][Full Text] [Related]
50. Cognition and behavior in patients with Alzheimer's disease.
Ott BR
J Gend Specif Med; 1999; 2(3):63-9. PubMed ID: 11252854
[TBL] [Abstract][Full Text] [Related]
51. Aromatase enzyme and Alzheimer's disease.
Hiltunen M; Iivonen S; Soininen H
Minerva Endocrinol; 2006 Mar; 31(1):61-73. PubMed ID: 16498364
[TBL] [Abstract][Full Text] [Related]
52. HRT and its effect on normal ageing of the brain and dementia.
Compton J; van Amelsvoort T; Murphy D
Br J Clin Pharmacol; 2001 Dec; 52(6):647-53. PubMed ID: 11736875
[TBL] [Abstract][Full Text] [Related]
53. Sex difference in biological change and mechanism of Alzheimer's disease: From macro- to micro-landscape.
Cui SS; Jiang QW; Chen SD
Ageing Res Rev; 2023 Jun; 87():101918. PubMed ID: 36967089
[TBL] [Abstract][Full Text] [Related]
54. Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease.
Rosario ER; Pike CJ
Brain Res Rev; 2008 Mar; 57(2):444-53. PubMed ID: 17658612
[TBL] [Abstract][Full Text] [Related]
55. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
56. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ;
Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897
[TBL] [Abstract][Full Text] [Related]
57. The role of hormone replacement therapy in the prevention of Alzheimer disease.
Fillit HM
Arch Intern Med; 2002 Sep; 162(17):1934-42. PubMed ID: 12230415
[TBL] [Abstract][Full Text] [Related]
58. Sex Differences in Alzheimer's Disease: Insights From the Multiomics Landscape.
Guo L; Zhong MB; Zhang L; Zhang B; Cai D
Biol Psychiatry; 2022 Jan; 91(1):61-71. PubMed ID: 33896621
[TBL] [Abstract][Full Text] [Related]
59. Estrogen Signaling in Alzheimer's Disease: Molecular Insights and Therapeutic Targets for Alzheimer's Dementia.
Uddin MS; Rahman MM; Jakaria M; Rahman MS; Hossain MS; Islam A; Ahmed M; Mathew B; Omar UM; Barreto GE; Ashraf GM
Mol Neurobiol; 2020 Jun; 57(6):2654-2670. PubMed ID: 32297302
[TBL] [Abstract][Full Text] [Related]
60. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
